Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioLineRx Ltd.

    NASDAQ: BLRX · Real-Time Price · USD
    5.87
    0.60 (11.39%)
    At close: Jun 06, 2025, 1:35 PM

    BioLineRx Statistics

    Share Statistics

    BioLineRx has 3.72M shares outstanding. The number of shares has increased by 74.04% in one year.

    Shares Outstanding

    n/a
    		 3.72M

    Shares Change (YoY)

    n/a
    		 74.04%

    Shares Change (QoQ)

    n/a
    		 34.18%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 770

    FTD / Avg. Volume

    n/a
    		 0.12%

    Short Selling Information

    The latest short interest is 181.45K, so 4.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 181.45K

    Short % of Shares Out

    n/a
    		 4.88%

    Short % of Float

    n/a
    		 4.89%

    Short Ratio (days to cover)

    n/a
    		 13.47

    Valuation Ratios

    The PE ratio is -74.15 and the forward PE ratio is -17.96. BioLineRx's PEG ratio is 0.84.

    PE Ratio

    n/a
    		 -74.15

    Forward PE

    n/a
    		 -17.96

    PS Ratio

    n/a
    		 23.63

    Forward PS

    n/a
    		 1

    PB Ratio

    n/a
    		 50.79

    P/FCF Ratio

    n/a
    		 -15.56

    PEG Ratio

    n/a
    		 0.84
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioLineRx.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.12.

    Current Ratio

    n/a
    		 1.76

    Quick Ratio

    n/a
    		 1.56

    Debt / Equity

    n/a
    		 1.12

    Debt / EBITDA

    n/a
    		 3.84

    Debt / FCF

    n/a
    		 -0.34

    Interest Coverage

    n/a
    		 -2.25

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,033,571.43

    Profits Per Employee

    n/a
    		 $-329,321.43

    Employee Count

    n/a
    		 28

    Asset Turnover

    n/a
    		 0.74

    Inventory Turnover

    n/a
    		 2.95

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -81.41% in the last 52 weeks. The beta is 0.86, so BioLineRx's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.86

    52-Week Price Change

    n/a
    		 -81.41%

    50-Day Moving Average

    n/a
    		 3.29

    200-Day Moving Average

    n/a
    		 10.61

    Relative Strength Index (RSI)

    n/a
    		 69.71

    Average Volume (20 Days)

    n/a
    		 625,819

    Income Statement

    In the last 12 months, BioLineRx had revenue of 28.94M and earned -9.22M in profits. Earnings per share was -0.12.

    Revenue

    n/a
    		 28.94M

    Gross Profit

    n/a
    		 19.68M

    Operating Income

    n/a
    		 -20.41M

    Net Income

    n/a
    		 -9.22M

    EBITDA

    n/a
    		 3.92M

    EBIT

    n/a
    		 -147K

    Earnings Per Share (EPS)

    n/a
    		 -0.12
    Full Income Statement

    Balance Sheet

    The company has 10.44M in cash and 15.04M in debt, giving a net cash position of -4.6M.

    Cash & Cash Equivalents

    n/a
    		 10.44M

    Total Debt

    n/a
    		 15.04M

    Net Cash

    n/a
    		 -4.6M

    Retained Earnings

    n/a
    		 -399.83M

    Total Assets

    n/a
    		 38.91M

    Working Capital

    n/a
    		 11.7M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -43.87M and capital expenditures -54K, giving a free cash flow of -43.93M.

    Operating Cash Flow

    n/a
    		 -43.87M

    Capital Expenditures

    n/a
    		 -54K

    Free Cash Flow

    n/a
    		 -43.93M

    FCF Per Share

    n/a
    		 -0.04
    Full Cash Flow Statement

    Margins

    Gross margin is 67.99%, with operating and profit margins of -70.52% and -31.86%.

    Gross Margin

    n/a
    		 67.99%

    Operating Margin

    n/a
    		 -70.52%

    Pretax Margin

    n/a
    		 -31.86%

    Profit Margin

    n/a
    		 -31.86%

    EBITDA Margin

    n/a
    		 13.54%

    EBIT Margin

    n/a
    		 -70.52%

    FCF Margin

    n/a
    		 -151.79%

    Dividends & Yields

    BLRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BLRX is $19, which is 266.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $19

    Price Target Difference

    n/a
    		 266.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 30, 2025. It was a backward split with a ratio of 1:40.

    Last Split Date

    n/a
    		 Jan 30, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:40

    Scores

    Altman Z-Score

    n/a
    		 -12.83

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist